Taro Pharmaceutical Industries Shares Outstanding 2006-2019 | TARO

Taro Pharmaceutical Industries shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Taro Pharmaceutical Industries Annual Shares Outstanding
(Millions of Shares)
2019 39
2018 40
2017 41
2016 43
2015 43
2014 44
2013 45
2012 44
2011
2011 41
2010
2010 41
2009 40
2008 35
2007 30
2006
2006
2005 30
Taro Pharmaceutical Industries Quarterly Shares Outstanding
(Millions of Shares)
2019-12-31 39
2019-09-30 39
2019-06-30 39
2019-03-31 39
2018-12-31 39
2018-09-30 39
2018-06-30 39
2018-03-31 40
2017-12-31 40
2017-09-30 40
2017-06-30 40
2017-03-31 41
2016-12-31 41
2016-09-30 41
2016-06-30 42
2016-03-31 43
2015-12-31 43
2015-09-30 43
2015-06-30 43
2015-03-31 43
2014-12-31 43
2014-09-30 43
2014-06-30 43
2014-03-31 43
2013-12-31 45
2013-09-30 45
2013-06-30 45
2013-03-31 45
2012-12-31 45
2012-09-30 45
2012-06-30 45
2012-03-31 45
2011-12-31 45
2011-09-30 45
2011-06-30 45
2011-03-31 44
2010-12-31 40
2010-09-30 41
2010-06-30 41
2010-03-31 41
2009-12-31
2009-09-30 41
2009-06-30 41
2009-03-31
2008-12-31 40
2008-09-30 40
2007-12-31
2006-12-31
2006-03-31
2005-12-31
2005-09-30 30
2005-06-30 30
2005-03-31 30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.418B $0.670B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.432B 31.49
Takeda Pharmaceutical (TAK) Japan $45.999B 8.06
Astellas Pharma (ALPMY) Japan $27.558B 13.76
Eisai (ESALY) Japan $19.334B 36.02
UCB SA (UCBJF) Belgium $15.687B 0.00
Grifols, S.A (GRFS) Spain $13.187B 16.39
Merck (MKGAF) Germany $12.536B 16.44
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $7.917B 219.95
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.164B 29.48
Ionis Pharmaceuticals (IONS) United States $6.754B 20.47
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.361B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.544B 6.76
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.597B 0.00
IPSEN SA ADR (IPSEY) France $4.543B 0.00
United Therapeutics (UTHR) United States $4.070B 0.00
Evotec AG (EVTCY) Germany $3.428B 55.29
Hypermarcas (HYPMY) Brazil $3.424B 10.41
Nektar Therapeutics (NKTR) United States $2.994B 0.00
FibroGen (FGEN) United States $2.866B 0.00
PTC Therapeutics (PTCT) United States $2.666B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.655B 49.28
ChemoCentryx (CCXI) United States $2.402B 0.00
Xencor (XNCR) United States $1.649B 67.35
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.620B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.561B 18.98
Theravance Biopharma (TBPH) Cayman Islands $1.439B 0.00
Sage Therapeutics (SAGE) United States $1.347B 0.00
USANA Health Sciences (USNA) United States $1.344B 14.11
Corcept Therapeutics (CORT) United States $1.335B 14.94
Pacira Pharmaceuticals (PCRX) United States $1.295B 35.40
Karyopharm Therapeutics (KPTI) United States $1.168B 0.00
Heron Therapeutics (HRTX) United States $1.056B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.010B 31.30
Zogenix (ZGNX) United States $1.010B 0.00
Akebia Therapeutics (AKBA) United States $0.874B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.859B 11.96
Esperion Therapeutics (ESPR) United States $0.846B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.781B 0.00
Endo (ENDP) Ireland $0.721B 1.33
ImmunoGen (IMGN) United States $0.596B 0.00
Tilray (TLRY) Canada $0.576B 0.00
Translate Bio (TBIO) United States $0.572B 0.00
Aerie Pharmaceuticals (AERI) United States $0.565B 0.00
Molecular Templates (MTEM) United States $0.561B 0.00
Collegium Pharmaceutical (COLL) United States $0.553B 0.00
Radius Health (RDUS) United States $0.550B 0.00
Portola Pharmaceuticals (PTLA) United States $0.504B 0.00
Indivior (INVVY) United States $0.397B 2.36
Siga Technologies (SIGA) United States $0.393B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.386B 15.84
Innate Pharma SA (IPHYF) France $0.385B 0.00
Ardelyx (ARDX) United States $0.378B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.365B 12.17
Corbus Pharmaceuticals Holdings (CRBP) United States $0.354B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.324B 0.00
Organogenesis Holdings (ORGO) United States $0.312B 0.00
Trillium Therapeutics (TRIL) Canada $0.301B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.301B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.299B 0.00
Calithera Biosciences (CALA) United States $0.286B 0.00
Lannett Co Inc (LCI) United States $0.285B 4.58
Harpoon Therapeutics (HARP) United States $0.277B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.263B 0.00
DURECT (DRRX) United States $0.260B 0.00
Flexion Therapeutics (FLXN) United States $0.256B 0.00
Ocular Therapeutix (OCUL) United States $0.251B 0.00
TherapeuticsMD (TXMD) United States $0.250B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.246B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.243B 0.00
Concert Pharmaceuticals (CNCE) United States $0.232B 0.00
Rafael Holdings (RFL) United States $0.186B 0.00
CASI Pharmaceuticals (CASI) United States $0.185B 0.00
Recro Pharma (REPH) United States $0.166B 0.00
OptiNose (OPTN) United States $0.164B 0.00
PROFOUND MEDICL (PROF) Canada $0.157B 0.00
MEI Pharma (MEIP) United States $0.155B 0.00
Jounce Therapeutics (JNCE) United States $0.145B 2.61
Nature's Sunshine Products (NATR) United States $0.140B 17.58
La Jolla Pharmaceutical (LJPC) United States $0.140B 0.00
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
KalVista Pharmaceuticals (KALV) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.120B 0.00
Redhill Biopharma (RDHL) Israel $0.104B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
IMV INC (IMV) Canada $0.086B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.084B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.081B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.081B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
SCYNEXIS (SCYX) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.074B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.068B 0.00
Biomerica (BMRA) United States $0.065B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
Xeris Pharmaceuticals (XERS) United States $0.064B 0.00
Aquestive Therapeutics (AQST) United States $0.062B 0.00
Otonomy (OTIC) United States $0.060B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 17.62
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.052B 0.00
Onconova Therapeutics (ONTX) United States $0.048B 0.00
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
Aclaris Therapeutics (ACRS) United States $0.046B 0.00
PharmAthene (ALT) United States $0.045B 0.00
GTx (ONCT) United States $0.044B 0.00
Natural Alternatives (NAII) United States $0.043B 19.47
MediWound (MDWD) Israel $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 133.57
Sundial Growers (SNDL) Canada $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Forward Pharma (FWP) Denmark $0.035B 0.00
PolarityTE (PTE) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.021B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Mannatechorporated (MTEX) United States $0.018B 5.78
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Novan (NOVN) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
KemPharm (KMPH) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00